Kimberly B. Bjugstad PhD's portrait

Kimberly B. Bjugstad PhD

About Kimberly B. Bjugstad PhD

Dr. Bjugstad received her PhD in Neuroscience from the University of South Florida. During her time as a research scientist, she has published more than 40 peer-reviewed articles and given over 75 conference presentations on topics including Alzheimer’s disease, heart disease, traumatic brain injury and male infertility.

Articles Written by Kimberly B. Bjugstad PhD

Sotagliflozin, the cardiovascular and renal benefits: Chapter 2
A detailed look at two studies investigating the benefits of using sotagliflozin in treating worsening heart failure in patients with type 2 diabetes and chronic kidney disease.
Sotagliflozin, the cardiovascular and renal benefits
An overview of two studies investigating the benefits of using sotagliflozin in treating worsening heart failure in patients with type 2 diabetes.
Estimating A1C Levels from CGM Data
Report of a recent study establishing how GMI can be used to track hypoglycemic events in patients with continuous glucose monitors.
Subclinical Hypothyroidism—What Is It? and Could It Affect Fertility?
Women who have infertility may also have subclinical hypothyroidism. Lower thyroid hormone levels should be addressed to improve pregnancy outcomes.
Malignant Nodules Can Be Identified by Their Location in the Thyroid
Malignant Nodules Can Be Identified By Their Location In The Thyroid
Sex Hormones May Be Key Weaponry in the Fight Against COVID-19
Male patients are at greater risk of severe complications from the Coronavirus
Is Alzheimer’s Disease Really Type 3 Diabetes?
Is Alzheimer's a diabetes of the brain?
Antenatal Corticosteroid Use Gets Boost From World Health Organization Study
The inexpensive drugs can be used in preterm labor to support a successful delivery
What Optogenetics Reveal About the Role of the Vagus Nerve in Appetite Suppression
Optogenetics and optoelectronic technology show promise in the future treatment of obesity by stimulating the vagus nerve with LED light.
FDA Approves First Drug for Thyroid Eye Disease
The first drug specifically for the treatment of thyroid eye disease has been approved by the FDA.

Financial Disclosures for Kimberly B. Bjugstad PhD

EndocrineWeb, a Remedy Health Media, LLC website, is committed to ensuring that the medical information it presents is accurate, balanced, objective, and trustworthy.

To help achieve this goal, EndocrineWeb requires all authors, editors, and reviewers to disclose any financial relationships or affiliations they have with companies whose products or services may be mentioned in the content they author, edit, or review.

The intent of this policy is to identify any perceived, potential, or real conflicts of interest so that readers can make their own judgments about the value of information being presented.

Author's Statement

I, the undersigned, declare that neither I nor members of my immediate family have a financial interests or affiliation with commercial companies whose products and / or services may be mentioned in the materials I have authored, edited or reviewed for presentation on Remedy Health Media, LLC’s websites.
There are no disclosures for this author